NS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NS PHARMA
Largest movements
- Tangible fixed assets -€36,294
down €36,294 (-8.6%), from €421,633 to €385,340
of which Land and buildings: -€21,600
- Receivables within one year +€25,335
up €25,335 (+500.4%), from €5,063 to €30,399
of which Trade receivables: +€20,675
- Deferred charges and accrued income +€24,259
up €24,259 (+44.5%), from €54,529 to €78,787
- Cash -€12,919
down €12,919 (-50.2%), from €25,718 to €12,799
mainly Current portion of long-term debt (-€47,339) and Receivables within one year (-€25,335)
- Current investments +€12,028
up €12,028 (+133.6%), from €9,000 to €21,028
- Current portion of long-term debt -€47,339
down €47,339 (-59.7%), from €79,332 to €31,993
- Trade debts +€30,969
up €30,969 (+41.8%), from €74,027 to €104,996
- Reserves +€25,025
up €25,025 (+10.8%), from €231,935 to €256,960
- Debts after one year -€18,407
down €18,407 (-6.9%), from €265,271 to €246,864
- Other debts +€7,802
up €7,802 (+2244.8%), from €348 to €8,150
- Gross operating margin -€14,185
down €14,185 (-6.2%), from €229,875 to €215,691
- Financial charges -€4,860
down €4,860 (-9.9%), from €49,161 to €44,301
- Taxes -€4,220
down €4,220 (-22.4%), from €18,855 to €14,635
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €674,795 | €691,656 | +€16,861 | +2.5% |
| Formation expenses | 20 | - | €0 | = | |
| Fixed assets | 21/28 | €421,658 | €385,365 | -€36,294 | -8.6% |
| Intangible fixed assets | 21 | - | €0 | = | |
| Tangible fixed assets | 22/27 | €421,633 | €385,340 | -€36,294 | -8.6% |
| Land and buildings | 22 | €288,600 | €267,000 | -€21,600 | -7.5% |
| Plant, machinery and equipment | 23 | €130,606 | €114,820 | -€15,786 | -12.1% |
| Furniture and vehicles | 24 | €2,428 | €3,520 | +€1,092 | +45.0% |
| Financial fixed assets | 28 | €25 | €25 | = | 0.0% |
| Current assets | 29/58 | €253,137 | €306,291 | +€53,154 | +21.0% |
| Stocks and contracts in progress | 3 | €158,827 | €163,278 | +€4,451 | +2.8% |
| Stocks | 30/36 | €158,827 | €163,278 | +€4,451 | +2.8% |
| Amounts receivable within one year | 40/41 | €5,063 | €30,399 | +€25,335 | +500.4% |
| Trade receivables | 40 | €3,043 | €23,717 | +€20,675 | +679.5% |
| Other amounts receivable | 41 | €2,021 | €6,681 | +€4,661 | +230.6% |
| Current investments | 50/53 | €9,000 | €21,028 | +€12,028 | +133.6% |
| Cash at bank and in hand | 54/58 | €25,718 | €12,799 | -€12,919 | -50.2% |
| Deferred charges and accrued income | 490/1 | €54,529 | €78,787 | +€24,259 | +44.5% |
| Total equity and liabilities | 10/49 | €674,795 | €691,656 | +€16,861 | +2.5% |
| Equity | 10/15 | €244,335 | €269,360 | +€25,025 | +10.2% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €231,935 | €256,960 | +€25,025 | +10.8% |
| Distributable reserves | 133 | €231,935 | €256,960 | +€25,025 | +10.8% |
| Amounts payable | 17/49 | €430,460 | €422,295 | -€8,164 | -1.9% |
| Amounts payable after more than one year | 17 | €265,271 | €246,864 | -€18,407 | -6.9% |
| Financial debts | 170/4 | €265,271 | €246,864 | -€18,407 | -6.9% |
| Amounts payable within one year | 42/48 | €165,189 | €173,182 | +€7,993 | +4.8% |
| Current portion of amounts payable after more than one year | 42 | €79,332 | €31,993 | -€47,339 | -59.7% |
| Financial debts | 43 | - | €3,841 | +€3,841 | |
| Credit institutions | 430/8 | - | €3,841 | +€3,841 | |
| Trade debts | 44 | €74,027 | €104,996 | +€30,969 | +41.8% |
| Suppliers | 440/4 | €74,027 | €104,996 | +€30,969 | +41.8% |
| Advances received on contracts in progress | 46 | - | €6,303 | +€6,303 | |
| Taxes, remuneration and social security | 45 | €11,482 | €17,899 | +€6,417 | +55.9% |
| Taxes | 450/3 | €3,244 | €5,175 | +€1,930 | +59.5% |
| Remuneration and social security | 454/9 | €8,238 | €12,724 | +€4,486 | +54.5% |
| Other amounts payable | 47/48 | €348 | €8,150 | +€7,802 | +2244.8% |
| Accrued charges and deferred income | 492/3 | - | €2,250 | +€2,250 | |
| Remuneration, social security and pensions | 62 | €58,189 | €58,994 | +€805 | +1.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €58,209 | €58,943 | +€735 | +1.3% |
| Other operating charges | 640/8 | €3,594 | €2,930 | -€664 | -18.5% |
| Gross operating margin | 9900 | €229,875 | €215,691 | -€14,185 | -6.2% |
| Operating profit (loss) | 9901 | €109,884 | €94,823 | -€15,061 | -13.7% |
| Financial income | 75/76B | €393 | €83 | -€310 | -78.9% |
| Recurring financial income | 75 | €393 | €83 | -€310 | -78.9% |
| Financial charges | 65/66B | €49,161 | €44,301 | -€4,860 | -9.9% |
| Recurring financial charges | 65 | €49,161 | €44,301 | -€4,860 | -9.9% |
| Profit (loss) for the period before taxes | 9903 | €61,116 | €50,605 | -€10,512 | -17.2% |
| Income taxes | 67/77 | €18,855 | €14,635 | -€4,220 | -22.4% |
| Profit (loss) for the period | 9904 | €42,261 | €35,970 | -€6,291 | -14.9% |
| Profit (loss) for the period to be appropriated | 9905 | €42,261 | €35,970 | -€6,291 | -14.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.